DCF — PEACEHEALTH SOUTHWEST MEDICAL CENTER
Enterprise Value: $-1.2B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.2B
Enterprise Value
$-395.5M
PV of Cash Flows
$-848.1M
PV of Terminal Value
$-1.4B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $838.2M | $-76.4M | -9.0% | $-111.9M | $-101.7M |
| Year 2 | $863.3M | $-70.0M | -8.0% | $-106.6M | $-88.1M |
| Year 3 | $889.2M | $-63.2M | -7.0% | $-100.9M | $-75.8M |
| Year 4 | $915.9M | $-60.6M | -7.0% | $-99.3M | $-67.8M |
| Year 5 | $943.4M | $-60.0M | -6.0% | $-99.9M | $-62.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.2B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$813.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09611190788885912
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5